[1]宿 娜,山周琦玥,辛 毅.乳腺癌患者426例临床特征及危险因素分析[J].陕西医学杂志,2023,52(12):1707-1710.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.017]
　SU Na,SHANZHOU Qiyue,XIN Yi.Clinical features and risk factors of 426 patients with breast cancer[J].,2023,52(12):1707-1710.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.017]
点击复制

乳腺癌患者426例临床特征及危险因素分析
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年12期
页码:
1707-1710
栏目:
临床研究
出版日期:
2023-12-05

文章信息/Info

Title:
Clinical features and risk factors of 426 patients with breast cancer
作者:
宿 娜1; 山周琦玥1; 辛 毅2
(1.崇州市人民医院肿瘤血液科,四川 崇州 611230; 2.崇州市人民医院甲乳外科,四川 崇州 611230)
Author(s):
SU Na; SHANZHOU Qiyue; XIN Yi
(Department of Oncology and Hematology,Chongzhou People's Hospital,Chongzhou 611230,China)
关键词:
乳腺癌;  临床特征;  危险因素;  预防;  保护因素
Keywords:
Breast cancer;  Clinical characteristics;  Risk factors;  Prevention;  Protective factor
分类号:
R 737.9
DOI:
DOI:10.3969/j.issn.1000-7377.2023.12.017
文献标志码:
A
摘要:
目的:分析乳腺癌患者临床特征及发病危险因素。方法:选取乳腺癌426例为乳腺癌组,按1:1比例纳入同期体检健康的女性426例为对照组。统计乳腺癌患者人口社会学特征,采用条件Logistic回归分析乳腺癌发病的危险因素。结果:426例乳腺癌患者中,发病年龄集中在41～50岁(43.90%),肿瘤多位于乳腺外上(51.41%),病理诊断多为浸润性导管癌(55.16%),其淋巴转移率也最高(65.53%),临床病理分期集中在Ⅱ期(73.24%),患者主要选择改良根治术治疗(81.69%)。经单因素分析发现,乳腺癌组与对照组年龄、职业、体重指数(BMI)、受教育水平、家庭年收入、婚姻状态、初潮时间、乳腺癌家族史、乳腺癌良性疾病史、生育史及哺乳史比较差异有统计学意义(均P<0.05),两组居住地、月经状态比较差异无统计学意义(均P>0.05)。条件Logistic回归分析提示,BMI≥30 kg/m2、初潮时间<12岁、乳腺癌家族史、乳腺癌良性疾病史是乳腺癌发病的危险因素,而哺乳史是乳腺癌发生的保护因素(均P<0.05)。结论:乳腺癌多发于41～50岁妇女,肿瘤多位于乳腺外上部,浸润性导管癌占比最高,目前改良根治术是乳腺癌主要治疗方式。BMI≥30 kg/m2、初潮时间<12岁及存在乳腺癌家族史、乳腺良性疾病史均是乳腺癌发病的危险因素,而哺乳史是乳腺癌发生的保护因素。
Abstract:
Objective:To investigate the clinical features and risk factors of 426 patients with breast cancer.Methods:A total of 426 women with breast cancer were enrolled as the breast cancer group,and 426 healthy women were enrolled as the control group at a ratio of 1:1.The demographic and sociological characteristics of breast cancer patients were analyzed,and the risk factors of breast cancer were analyzed by conditional Logistic regression.Results:Among the 426 patients with breast cancer,the age of onset was concentrated between 41 and 50 years old(43.90%),the tumors were mostly located in the outer upper breast(51.41%),the pathological diagnosis was mostly invasive ductal carcinoma(55.16%)and the lymph node metastasis rate was the highest(65.53%),and the clinical pathological stage was concentrated in stage Ⅱ(73.24%),and most patients chose modified radical surgery(81.69%).Single factor analysis found that the age,occupation,BMI,education level,family income,marital status,menstruation,family history of breast cancer,breast cancer,benign disease history,family history,and lactation history in breast cancer group were statistically different from control group(all P<0.05),and there were no significant differences in residence and menstrual status between the two groups(all P>0.05).Conditional Logistic regression analysis showed that BMI ≥30 kg/m2,menarche time <12 years old,family history of breast cancer,and history of benign breast cancer were risk factors for breast cancer,while breast-feeding history was a protective factor for breast cancer(all P<0.05).Conclusion:Breast cancer mostly occurs in women aged 41 to 50 years old,and the tumors are mostly located in the outer upper breast,with invasive ductal carcinoma accounting for the highest proportion.Modified radical mastectomy is the main treatment for breast cancer at present.BMI ≥30 kg/m2,menarche time <12 years old,family history of breast cancer and history of benign breast diseases are risk factors for breast cancer,while breast-feeding history is protective factor for breast cancer.

参考文献/References:

[1] 邵志博,杨犇龙,吴 炅.2022年中国乳腺癌重要临床试验成果及最新进展[J].中国癌症杂志,2023,33(2):103-109.
[2] 邹腾跃,邹芳芳,孙亚君,等.烟酰胺磷酸核糖基转移酶及沉默信息调节因子2同源蛋白1在乳腺癌组织中的表达及与患者临床病理特征的关系[J].陕西医学杂志,2023,52(8):1093-1096,1101.
[3] 刘小娜,郝 娜,马晓霞,等.三黄煎剂联合吡柔比星、多西他赛、环磷酰胺新辅助化疗治疗三阴乳腺癌临床研究[J].陕西中医,2021,42(10):1367-1370.
[4] 沈 亮,杨 蕴,张颂文,等.乳腺癌组织中lncRNA ARHGAP5-AS1的表达观察及患者预后影响因素分析[J].山东医药,2021,61(24):5-9.
[5] 吕民豪,焦得闯,吴军召,等.乳腺癌新辅助化疗后同侧锁骨上淋巴结病理完全缓解列线图预测模型的构建[J].中华肿瘤杂志,2022,44(2):160-166.
[6] 李 贺,左婷婷,曾红梅,等.不同年龄女性乳腺癌患者的临床特征及预后分析[J].中华肿瘤杂志,2021,43(1):126-131.
[7] 刘雪薇,王 媛,韦丹梅,等.1990—2019年中国女性乳腺癌发病及死亡趋势的年龄-时期-队列模型分析[J].中国全科医学,2023,26(1):34-41.
[8] 陈玮黎,薛晓红,李思雨,等.扶正祛邪方对三阴性乳腺癌术后复发转移及免疫功能的影响[J].陕西中医,2021,42(6):739-742.
[9] 蔡振海,杨朝蓉,黄伟斌,等.揭阳地区乳腺癌临床流行病学特征分析[J].广东医学,2021,42(6):701-705.
[10] 李慧芳,郭晨明,王海燕,等.新疆乌鲁木齐市某三甲医院1701例乳腺癌患者流行病学分析[J].实用癌症杂志,2022,37(6):975-979.
[11] 刘蕴宇,贾新建,吕亚兰,等.重庆市1921例女性乳腺癌住院患者临床流行病学及病理特征回顾性分析[J].第二军医大学学报,2021,42(6):617-625.
[12] 李福平,王 茂,邱春丽,等.莱菔硫烷联合维生素D对乳腺癌细胞增殖及凋亡的影响[J].陕西医学杂志,2022,51(8):916-920.
[13] 李军成,何升东,孙 鹏,等.基于上皮-间质转化标记的循环肿瘤细胞表型检测对原发性乳腺癌的预后评估意义[J].成都医学院学报,2021,16(2):165-168,172.
[14] 张小凡,刁 莎,李 旭,李佳圆.不同肥胖测量指标对血浆C反应蛋白与乳腺癌患病风险关系的影响[J].中国慢性病预防与控制,2021,29(4):254-258.
[15] 王昭君,马海广,胡晓清,等.体质指数和绝经后乳腺癌患者临床病理因素的关系[J].中国妇幼保健,2022,37(12):2144-2147.
[16] 陈清卫,刘 蕾,江 哲,等.邢台地区乳腺癌发病的影响因素分析[J].河北医药,2022,44(8):1248-1251.
[17] 周 丹,陈佩贤,杨树清,等.Gail风险评估模型预测珠三角广佛地区女性散发性乳腺癌风险的适用性研究[J].天津医药,2021,49(8):874-877.
[18] 李金穗,徐明飞,李静佳,等.基于公共数据库分析雄激素受体与MLPH在乳腺癌组织中的表达及其相关性[J].川北医学院学报,2023,38(3):303-308.
[19] 仇 艳,王 惠,凌梦妍.生殖因素与三阴性乳腺癌发生和预后的关系[J].中国妇幼保健,2022,37(2):226-229.
[20] 刘慧婷,王德斌,沈兴蓉,等.安徽省女性乳腺癌危险因素分析与风险预测模型研究[J].蚌埠医学院学报,2022,47(5):661-664.
[21] 胡 琴,李爱玲,蒋德勇,等.2016—2018年泸州市女性乳腺癌流行病学负担研究[J].现代预防医学,2022,49(1):12-16.
[22] 翟 洁,孔祥溢,方 仪,等.乳腺癌与甲状腺癌双原发的临床特征及预后[J].中华肿瘤杂志,2021,43(12):1287-1291.
[23] 刘 勇,刘振华,徐小兰,等.儋州地区≥40岁女性乳腺癌筛查结果及影响因素分析[J].华南预防医学,2022,48(9):1122-1125.

相似文献/References:

[1]乔亚舜,吴瑛琦.乳腔镜腋窝淋巴结清扫术治疗早期乳腺癌临床研究[J].陕西医学杂志,2019,(4):473.
　QIAO Yashun,WU Yingqi..Clinical study of mammoscopic axillary lymph node dissection for early breast cancer patients[J].,2019,(12):473.
[2]谭兴利,陆伟辉,汤学文,等.乳腺癌患者超声检查中PSV、RI值与术后组织中MMP11、VEGF表达的相关性探讨[J].陕西医学杂志,2019,(5):617.
[3]韩丕华,宋张骏△,杨晓民,等.乳腺超声造影联合细针穿刺定位活检在判定乳腺癌新辅助化疗后腋窝淋巴结性质中的临床研究*[J].陕西医学杂志,2019,(7):842.
　HAN Pihua,SONG Zhangjun,YANG Xiaomin,et al.Application of breast contrast-enhanced ultrasonography combined with fine needle aspiration biopsy in determining the axillary lymph node properties after neoadjuvant chemotherapy for breast cancer[J].,2019,(12):842.
[4]蒋 敢,王 军,王会东△.舒芬太尼联合罗哌卡因肋间神经阻滞对乳腺癌患者术后镇痛、免疫功能及应激反应的影响*[J].陕西医学杂志,2019,(8):1077.
　JIANG Gan,WANG Jun,WANG Huidong..Effect of sufentanil plus ropivacaine intercostal nerve block on postoperative analgesia, immunity and stress response in patients with breast cancer[J].,2019,(12):1077.
[5]王群拴,黎小花△.核磁共振结合血清肿瘤标志物及细胞因子检测在〖JZ〗乳腺癌诊断中的应用价值研究*[J].陕西医学杂志,2019,(10):1295.
[6]杨建华,马伟欢△,宁 博,等.陕西宝鸡市新型冠状病毒肺炎流行病学及临床特征分析[J].陕西医学杂志,2020,49(5):519.
　YANG Jianhua,MA Weihuan,Ning Bo,et al.Epidemiological and clinical characteristics of NCP patients in Baoji,Shaanxi[J].,2020,49(12):519.
[7]王素娜,姚 娜,汪春付,等.新型冠状病毒肺炎39例临床特征分析*[J].陕西医学杂志,2020,49(6):643.[doi:DOI:10.3969/j.issn.10007377.2020.06.001]
　WANG Suna,YAO Na,WANG Chunfu,et al.Epidemiological and clinical characteristics of COVID-19 in Shaanxi,China[J].,2020,49(12):643.[doi:DOI:10.3969/j.issn.10007377.2020.06.001]
[8]韩丕华,袁 权△.乳腺癌患者白细胞介素-22表达水平对新辅助化疗后病理学完全缓解的预测价值*[J].陕西医学杂志,2020,49(7):889.[doi:DOI:10.3969/j.issn.10007377.2020.07.033]
　HAN Pihua,YUAN Quan..Predictive value of IL-22 expression level in breast cancer patients for pathological complete remission after neoadjuvant chemotherapy[J].,2020,49(12):889.[doi:DOI:10.3969/j.issn.10007377.2020.07.033]
[9]师 瑜,杨明珠,张娇蕊,等.传染性单核细胞增多症合并多种病原体感染患儿临床特征和预后研究*[J].陕西医学杂志,2020,49(11):1453.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.021]
　SHI Yu,YANG Mingzhu,ZHANG Jiaorui,et al.Clinical features and prognosis of children with infectious mononucleosis complicated by multiple pathogen infections[J].,2020,49(12):1453.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.021]
[10]刘 丹,梁新新.育龄期子宫内膜异位症合并不孕症患者临床特征及腹腔镜术后辅助生殖妊娠结局影响因素分析[J].陕西医学杂志,2021,50(4):409.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.006]
　LIU Dan,LIANG Xinxin.Clinical characteristics of endometriosis patients with infertility in childbearing age and influencing factors of assisted reproductive pregnancy outcome after laparoscopic surgery[J].,2021,50(12):409.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.006]
[11]郭倩倩,苏志勇.乳腺癌术后恶性胸腔积液临床特征及预后Cox回归分析[J].陕西医学杂志,2024,(2):203.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.012]

备注/Memo

备注/Memo:
基金项目:四川省医学青年创新科研课题(Q22080)
更新日期/Last Update: 2023-12-05